Comments to the NMPA on Measures for the Implementation of the Early Resolution Mechanism for Drug Patent Disputes (Trial)
2020-10-25 | Beijing, Shanghai
The Legal and IPR WGs submitted revision suggestions on issues including patent registration for drugs and litigation time limit.